Abstract
Radiotherapy of lung cancer may cause pneumonitis that generally occurs weeks or months following therapy and can be missed. This prospective trial aimed to pave the way for a mobile application (app) allowing early diagnosis of pneumonitis. The primary goal was the identification of the optimal cut-off of a score to detect pneumonitis of grade ≥2 after radiotherapy for lung cancer. Based on the severity of symptoms (cough, dyspnea, fever), scoring points were 0–9. Receiver operating characteristic (ROC)-curves were used to describe the sensitivity and specificity. The area under the ROC-curve (AUC) was calculated to judge the accuracy of the score, Youden-index was employed to define the optimal cut-off. Until trial termination, 57 of 98 patients were included. Eight of 42 patients evaluable for the primary endpoint (presence or absence of radiation pneumonitis) experienced pneumonitis. AUC was 0.987 (0.961–1.000). The highest sensitivity was achieved with 0–4 points (100%), followed by 5 points (87.5%), highest specificity with 5–6 points (100%). The highest Youden-index was found for 5 points (87.5%). The rate of patient satisfaction with the symptom-based scoring system was 93.5%. A cut-off of 5 points was identified as optimal to differentiate between pneumonitis and no pneumonitis. Moreover, pneumonitis was significantly associated with an increase of ≥3 points from baseline (p < 0.0001). The scoring system provided excellent accuracy and high patient satisfaction. Important foundations for the development of a mobile application were laid.
Funder
European Regional Development Fund through the Interreg Deutschland-Danmark program
Reference21 articles.
1. Leitlinienprogramm (2022). Onkologie: Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms, Leitlinienprogramm Onkologie. Available online: https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/LL_Lungenkarzinom_Langversion_2.01.pdf.
2. Verma, V., Simone, C.B., and Werner-Wasik, M. (2017). Acute and late toxicities of concurrent chemoradiotherapy for locally-advanced non-small cell lung cancer. Cancers, 9.
3. Prevalence and characteristics of symptomatic pneumonitis after radiotherapy of patients with locally advanced lung cancer;Rades;Anticancer Res.,2019
4. Radiation induced lung injury: Prediction, assessment and management;Giridhar;Asian Pac. J. Cancer Prev.,2015
5. Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy;Dang;Acta Oncol.,2013